Published in Med Clin North Am on March 01, 2010
Inflammation in atherosclerosis. Nature (2002) 28.92
The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (1993) 27.07
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet (1996) 16.32
Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. Ann Intern Med (1961) 12.08
Coronary anomalies: incidence, pathophysiology, and clinical relevance. Circulation (2002) 11.23
Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med (1987) 9.79
Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med (1959) 8.04
Pathophysiology of coronary artery disease. Circulation (2005) 6.65
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol (2004) 6.50
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J (2006) 5.79
Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med (1993) 5.04
Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med (1999) 5.01
Hemodynamically significant primary anomalies of the coronary arteries. Angiographic aspects. Circulation (1978) 4.36
Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol (1998) 4.19
Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation (2001) 3.38
Angina pectoris caused by coronary microvascular spasm. Lancet (1998) 3.01
Angina with "normal" coronary arteries: a changing philosophy. JAMA (2005) 2.98
Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation (2009) 2.88
Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial. J Am Coll Cardiol (2006) 2.79
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. JAMA (2007) 2.57
Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Cardiol (2004) 2.31
Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA (1988) 2.30
Persistent chest pain and no obstructive coronary artery disease. JAMA (2009) 2.27
The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times. Am Heart J (1989) 2.25
Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation (2005) 2.06
Cardiac positron emission tomography. J Am Coll Cardiol (2009) 1.96
Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation (2006) 1.95
Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation (1986) 1.84
Matching coronary blood flow to myocardial oxygen consumption. J Appl Physiol (1985) (2004) 1.83
Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol (1983) 1.82
Evaluation of primary care patients with chronic stable angina: guidelines from the American College of Physicians. Ann Intern Med (2004) 1.78
Angina pectoris in patients with aortic stenosis and normal coronary arteries. Mechanisms and pathophysiological concepts. Circulation (1997) 1.76
Reduced coronary dilatory capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms. Circulation (1981) 1.68
Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women. Heart (1998) 1.68
Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc Surg (1996) 1.64
Positron emission tomography and molecular imaging. Heart (2008) 1.60
Abnormal cortical pain processing in patients with cardiac syndrome X. Eur Heart J (2005) 1.60
Guidelines for the management of patients with chronic stable angina: diagnosis and risk stratification. Ann Intern Med (2001) 1.44
Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST) Circulation (1994) 1.43
Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations. Circulation (2003) 1.41
Nonspecific electrocardiographic abnormality as a predictor of coronary heart disease: the Framingham Study. Am Heart J (1987) 1.39
Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial. Health Technol Assess (2007) 1.38
Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. N Engl J Med (1984) 1.36
Regulation of coronary blood flow. Prog Cardiovasc Dis (1975) 1.21
Multivessel coronary spasm in patients with variant angina: a study with intracoronary injection of acetylcholine. Circulation (1988) 1.16
Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial. J Am Coll Cardiol (2009) 1.13
Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries. J Am Coll Cardiol (1990) 1.05
Direct vasoconstriction and endothelium-dependent vasodilation. Mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries. Circulation (1989) 1.05
Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol (2000) 1.05
Central neural contribution to the perception of chest pain in cardiac syndrome X. Heart (2002) 1.02
Hemodynamic mechanisms responsible for reduced subendocardial coronary reserve in dogs with severe left ventricular hypertrophy. Circulation (1995) 1.01
Endothelial function and coronary spastic angina. Intern Med (2005) 1.00
Functionally significant versus intriguingly different coronary artery anatomy: anatomo-clinical correlations in coronary anomalies. G Ital Cardiol (1999) 1.00
Is altered cardiac sensation responsible for chest pain in patients with normal coronary arteries? Clinical observation during cardiac catheterisation. Br Med J (Clin Res Ed) (1988) 0.98
Mitral valve prolapse, panic disorder, and chest pain. Med Clin North Am (1991) 0.97
Why angina pectoris in aortic stenosis. Circulation (1997) 0.96
Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease. Am J Cardiol (2005) 0.95
Abnormal cardiac pain perception in syndrome X. J Am Coll Cardiol (1994) 0.94
Women and cardiovascular heart disease: clinical implications from the Women's Ischemia Syndrome Evaluation (WISE) Study. Are we smarter? J Am Coll Cardiol (2006) 0.93
Why angina in aortic stenosis with normal coronary arteriograms? Circulation (2003) 0.92
The value of routine non-invasive tests to predict clinical outcome in stable angina. Eur Heart J (2003) 0.87
Pharmacological stress testing. Semin Nucl Med (1999) 0.85
Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction. J Am Coll Cardiol (1995) 0.85
The pathophysiology of chronic ischemic heart disease. Clin Cardiol (2007) 0.85
Abnormal coronary flow dynamics at rest and during tachycardia associated with impaired left ventricular relaxation in humans: implication for tachycardia-induced myocardial ischemia. J Am Coll Cardiol (1994) 0.85
Cardiac syndrome X in women: the role of oestrogen deficiency. Heart (2006) 0.85
Microvascular angina. The possible role of inflammation, uric acid, and endothelial dysfunction. Int Heart J (2009) 0.82
Coronary heart disease in residents of Rochester, Minnesota. IV. Prognostic value of the resting electrocardiogram at the time of initial diagnosis of angina pectoris. Mayo Clin Proc (1984) 0.82
Validity of electron beam computed tomography for coronary artery disease: asystematic review and meta-analysis. BMC Med (2007) 0.81
Comparison of pharmacologic stress agents. J Nucl Cardiol (1997) 0.79
Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study. Expert Rev Cardiovasc Ther (2008) 0.78
Increased peripheral circulating inflammatory cells and plasma inflammatory markers in patients with variant angina. Coron Artery Dis (2008) 0.78
A review of electron beam computed tomography: implications for coronary artery disease screening. Prev Cardiol (2002) 0.77
Mitral valve prolapse: left ventricular hemodynamics in patients with chest pain, dyspnea or both. J Heart Valve Dis (1993) 0.76
Utility of stress testing and coronary calcification measurement for detection of coronary artery disease in women. Arch Intern Med (2004) 0.76
Tomographic coronary angiography by EBCT and MDCT. Prog Cardiovasc Dis (2003) 0.76
Non-invasive tests in coronary artery disease: are we facing a fork in the road? Heart (2007) 0.75
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18
Angina with "normal" coronary arteries: a changing philosophy. JAMA (2005) 2.98
Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE). Circulation (2007) 2.82
Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol (2010) 2.68
Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J (2006) 2.67
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol (2006) 2.57
Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation (2004) 2.50
Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. J Am Coll Cardiol (2007) 2.49
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation (2004) 2.30
Retracted Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab (2008) 2.21
Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol (2009) 2.01
Heart rate response to exercise stress testing in asymptomatic women: the st. James women take heart project. Circulation (2010) 1.93
Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. JACC Cardiovasc Imaging (2011) 1.75
Effects of yoga on inflammation and exercise capacity in patients with chronic heart failure. J Card Fail (2008) 1.48
Some thoughts on the vasculopathy of women with ischemic heart disease. J Am Coll Cardiol (2006) 1.45
Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: A report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Arch Gen Psychiatry (2009) 1.45
Reproductive hormone exposure timing and ischemic heart disease: Complicated answers to a simple question. Maturitas (2010) 1.39
Social networks are associated with lower mortality rates among women with suspected coronary disease: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation study. Psychosom Med (2004) 1.36
Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol (2009) 1.31
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. JACC Cardiovasc Interv (2012) 1.30
Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation (2004) 1.28
Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC Cardiovasc Imaging (2011) 1.23
The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol (2006) 1.23
Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. JACC Cardiovasc Imaging (2010) 1.21
Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. J Am Coll Cardiol (2004) 1.21
An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). J Interv Cardiol (2010) 1.14
Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol (2006) 1.12
Maternal recall of hypertensive disorders in pregnancy: a systematic review. J Womens Health (Larchmt) (2012) 1.11
Depression and cardiovascular health care costs among women with suspected myocardial ischemia: prospective results from the WISE (Women's Ischemia Syndrome Evaluation) Study. J Am Coll Cardiol (2009) 1.10
Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management. Curr Probl Cardiol (2011) 1.08
Myocardial ischemia in women: lessons from the NHLBI WISE study. Clin Cardiol (2012) 1.07
Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease. Circulation (2003) 1.07
Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software. Cardiovasc Diagn Ther (2012) 1.05
Benefits of yoga for African American heart failure patients. Med Sci Sports Exerc (2010) 1.00
Recognizing Sex Similarities in Cardiovascular Disease Research. J Am Coll Cardiol (2015) 0.99
Cardiac magnetic resonance imaging myocardial perfusion reserve index assessment in women with microvascular coronary dysfunction and reference controls. Cardiovasc Diagn Ther (2013) 0.96
Anger, hostility, and cardiac symptoms in women with suspected coronary artery disease: the Women's Ischemia Syndrome Evaluation (WISE) Study. J Womens Health (Larchmt) (2006) 0.95
Migraines, angiographic coronary artery disease and cardiovascular outcomes in women. Am J Med (2006) 0.95
Psychosocial stress and cardiovascular disease Part 2: effectiveness of the Transcendental Meditation program in treatment and prevention. Behav Med (2002) 0.95
Anginal symptoms, coronary artery disease, and adverse outcomes in Black and White women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. J Womens Health (Larchmt) (2013) 0.92
Lipid-lowering medication use and aggression scores in women: a report from the NHLBI-sponsored WISE study. J Womens Health (Larchmt) (2008) 0.90
Cardiac symptoms in women and men. JAMA Intern Med (2013) 0.90
Symptoms, myocardial ischaemia and quality of life in women: results from the NHLBI-sponsored WISE Study. Eur Heart J (2003) 0.90
Self-rated versus objective health indicators as predictors of major cardiovascular events: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation. Psychosom Med (2010) 0.90
DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Clin Endocrinol Metab (2010) 0.89
The association of hormone replacement therapy and coronary calcium as determined by electron beam tomography. J Womens Health Gend Based Med (2002) 0.89
Obesity distribution and reproductive hormone levels in women: a report from the NHLBI-sponsored WISE Study. J Womens Health (Larchmt) (2006) 0.88
Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol (2006) 0.88
Non-ECG-gated myocardial perfusion MRI using continuous magnetization-driven radial sampling. Magn Reson Med (2014) 0.88
Effects of oral magnesium therapy on exercise tolerance, exercise-induced chest pain, and quality of life in patients with coronary artery disease. Am J Cardiol (2003) 0.87
Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women's Ischemia Syndrome Evaluation (WISE) ancillary study. Clin Cardiol (2011) 0.86
Women and ischemic heart disease paradox and pathophysiology. JACC Cardiovasc Imaging (2011) 0.86
Treatment of angina and microvascular coronary dysfunction. Curr Treat Options Cardiovasc Med (2010) 0.85
APOE polymorphism and angiographic coronary artery disease severity in the Women's Ischemia Syndrome Evaluation (WISE) study. Atherosclerosis (2003) 0.85
Carotid wall thickness and years since bilateral oophorectomy: the Los Angeles Atherosclerosis Study. Am J Epidemiol (2002) 0.85
Anxiety associations with cardiac symptoms, angiographic disease severity, and healthcare utilization: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation. Int J Cardiol (2013) 0.85
Women and heart disease: knowledge, worry, and motivation. J Womens Health (Larchmt) (2011) 0.84
The Who, What, Why, When, How and Where of Vasospastic Angina. Circ J (2015) 0.84
Microvascular angina: an underappreciated cause of SLE chest pain. J Rheumatol (2013) 0.83
Quantification of I-123-meta-iodobenzylguanidine heart-to-mediastinum ratios: not so simple after all. J Nucl Cardiol (2014) 0.82
Improved quantification of myocardial blood flow using highly constrained back projection reconstruction. Magn Reson Med (2013) 0.81
Increased wave reflection and ejection duration in women with chest pain and nonobstructive coronary artery disease: ancillary study from the Women's Ischemia Syndrome Evaluation. J Hypertens (2013) 0.81
Vascular smooth muscle insulin resistance, but not hypertrophic signaling, is independent of angiotensin II-induced IRS-1 phosphorylation by JNK. Am J Physiol Cell Physiol (2011) 0.81
The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles Atherosclerosis Study. J Clin Endocrinol Metab (2010) 0.81
Comparison of SWAN and WISE menopausal status classification algorithms. J Womens Health (Larchmt) (2006) 0.81
Gender and microvascular angina. J Thromb Thrombolysis (2011) 0.81
Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood Institute sponsored WISE study). Am J Cardiol (2008) 0.80
Hormone replacement, race, and psychological health in women: a report from the NHLBI-Sponsored WISE Study. J Womens Health (Larchmt) (2004) 0.80
Effects of sex and gender on adaptation to space: cardiovascular alterations. J Womens Health (Larchmt) (2014) 0.79
Doing more good than harm: need for a cease fire. Am J Med (2009) 0.79
Oral contraceptive use and the ECG: evidence of an adverse QT effect on corrected QT interval. Ann Noninvasive Electrocardiol (2013) 0.79
Is cardiovascular disease in women inevitable?: preparing for menopause and beyond. Cardiol Rev (2011) 0.79
Cardiac risk factors and myocardial perfusion reserve in women with microvascular coronary dysfunction. Cardiovasc Diagn Ther (2013) 0.78
Phytoestrogens and coronary microvascular function in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE) Study. J Womens Health (Larchmt) (2007) 0.78
Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol (2005) 0.78
Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE). Menopause (2016) 0.77
Adverse Pregnancy Conditions, Infertility, and Future Cardiovascular Risk: Implications for Mother and Child. Cardiovasc Drugs Ther (2015) 0.77
Differing Relations to Early Atherosclerosis between Vitamin C from Supplements vs. Food in the Los Angeles Atherosclerosis Study: A Prospective Cohort Study. Open Cardiovasc Med J (2012) 0.77
President's page: the promise of prevention: so, why aren't all cardiologists "preventive"? J Am Coll Cardiol (2004) 0.76
Correction: The Association of Statin Use after Cancer Diagnosis with Survival in Pancreatic Cancer Patients: A SEER-Medicare Analysis. PLoS One (2015) 0.75
Therapy for stable angina in women. P T (2012) 0.75
Contraception in patients with heart failure. Circulation (2012) 0.75
Cardiovascular disease and endometrial cancer. Gynecol Oncol (2012) 0.75
The joint impact of smoking and exercise capacity on clinical outcomes among women with suspected myocardial ischemia: the WISE study. J Womens Health (Larchmt) (2009) 0.75
Advancing Women's Health and Women's Leadership With Endowed Chairs in Women's Health. Acad Med (2016) 0.75
Subendocardial ischemia and myocarditis in systemic lupus erythematosus detected by cardiac magnetic resonance imaging. J Rheumatol (2012) 0.75
Are we 'WISE'r? Findings from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation study. Womens Health (Lond Engl) (2006) 0.75
Reply: Association Between Migraine Headache and Cardiac Syndrome X. J Am Coll Cardiol (2016) 0.75